A miRNA signature assessing ovarian cancer prognosis
Oncoscience
.
2016 Dec 2;3(11-12):308-310.
doi: 10.18632/oncoscience.329.
eCollection 2016.
Authors
Marina Bagnoli
1
,
Sandro Pignata
1
,
Delia Mezzanzanica
1
Affiliation
1
Molecular Therapies Unit, Dept of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori Milan, Milan, Italy.
PMID:
28105451
PMCID:
PMC5235915
DOI:
10.18632/oncoscience.329
No abstract available
Keywords:
MITO translational group; early relapse; miR-506 family; microRNA; ovarian cancer.
Publication types
Editorial